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Abstract 
The addition of the potassium salt of (R)-4-phenyl-2-oxazolidinone to dialkyl alkylidenemalonates 
under various conditions is reported. Very good diastereoselectivities (> 90% de) were obtained in 
several cases. Conversion of one of the adducts to the β-amino acid (S)-β-leucine was achieved in 
two straightforward steps. 
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Introduction 
 
β-Amino acids are components or precursors of many bioactive substances and thus methods for 
their asymmetric synthesis have been developed using various strategies.1-3 Among these, 
approaches involving an aza-Michael reaction have often been used. In this process, the 
asymmetric induction may come either from a chiral nitrogen nucleophile,4-6 or from a chiral 
conjugate electrophile,7-11 or from a chiral ligand, employed either stoichiometrically12,13 or 
catalytically.14-16 
We previously reported the highly diastereoselective conjugate addition of (R)- and (S)-
4-phenyl-2-oxazolidinone to nitroalkenes.17 The corresponding adducts then served as precursors to 
enantiopure β-amino acids,18 1,2-diamines,17,18 and amines,19 which were obtained after 
modification of the nitro function and cleavage of the oxazolidinone moiety to release an amine 
function. In this article, we report the results obtained in the conjugate addition of (R)-4-phenyl-2-
oxazolidinone to dialkyl alkylidenemalonates, leading to precursors of β-amino acids. 
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Results and Discussion 
 
Preliminary attempts to perform the conjugate addition of the potassium salt of 4-phenyl-2-
oxazolidinone 1 to alkenes activated by only one ester function, methyl crotonate and methyl 
cinnamate were unsuccessful. It should be noted that the conjugate addition of 2-oxazolidinone to 
methyl acrylate, catalyzed by either 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU)20 or 
tetramethylammonium fluoride21 has been reported. In our case, it was obvious that more activated 
electrophiles had to be employed, and dialkyl alkylidenemalonates 2 were then tested. Compounds 
2 were obtained from commercial sources or prepared from dimethyl malonate, according to 
reported procedures,22,23 and several conjugate additions were then performed (Scheme 1). 
 
 
 
Scheme 1. Conjugate addition of (R)-4-phenyl-2-oxazolidinone 1 to dialkyl alkylidenemalonates. 
 
The potassium salt of oxazolidinone 1 was generated in THF at 0 °C by addition of potassium 
tert-butoxide, either in the presence of 18-crown-6 or not. After 30 min at 0 °C, the suspension 
obtained was cooled at –78 °C, and a solution of dialkyl alkylidenemalonate in THF was added. In 
the first experiments, the temperature was allowed to reach room temperature; however, in these 
conditions, no adduct was isolated, which was attributed to a retroaddition at room temperature. 
Three different conditions were then employed in the other experiments: The reaction mixture was 
stirred at –78 °C for 1–6 h and then hydrolyzed (method A); or the reaction mixture was stirred 
at -78 °C for 1 h, then stirred at –20 °C for 1 h (method B) or for 12 h (method C) and then 
hydrolyzed (Table 1). 
Unlike the conjugated mono-esters, most tested dialkyl alkylidenemalonates reacted with the 
salt of oxazolidinone 1, and several reactions proceeded with diastereomeric excesses (de) of 90% 
or more. The diastereoselectivity depended on the nature of the R group. Hence, good 
diastereoisomeric excesses were obtained starting from compounds 2 where R = isopropyl, 
cyclohexyl and phenyl, but not from compound 2a, where R = methyl, a smaller group. This 
suggested that the diastereofacial selectivity improved when the R group was more sterically 
demanding. However, no reaction was observed starting from a malonate bearing the more 
crowded tert-butyl group (entry 8). 
In several cases where the reaction mixture was maintained at –78 °C, the yields were poor, 
owing to incomplete additions (entries 1,9 and 11). Adding one equivalent of 18-crown-6 improved 
the yield, but had a negative impact on the diastereoselectivity (entry 2). The yield was usually 
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better when the temperature was raised to -20 °C prior to the addition of water. However, the 
reaction was still incomplete after 12 h in some cases (entries 3 and 4). 
 
Table 1. Preparation of oxazolidinones 3 
Entry R R’ Product 18-Crown-6 (equiv) De
d
 Yield (%) 
1 Me Et 3aa 0 36 50 
2 Me Et 3aa 1 28 99 
3 Et Me 3bc 0 67 37 
4 pentyl Me 3cc 0 45 43 
5 iBu Me 3dc 0 41 65 
6 iPr Me 3eb 0 91 60 
7 iPr Me 3ec 0 92 63 
8 tBu Me 3fb 1 - 0 
9 cyclohexyl Me 3ga 0 94 21 
10 cyclohexyl Me 3gb 1 46 77 
11 Ph Me 3ha 0 98 30 
12 Ph Me 3hb 1 90 70 
a
 Method A (see text). b Method B (see text). c Method C (see text). d Diastereomeric excess 
determined by 1H NMR. 
 
The major diastereoisomer of adduct 3h, obtained from (R)-4-phenyl-2-oxazolidinone and 
dimethyl benzylidenemalonate was isolated by crystallization and single crystal X-ray diffraction 
studies established the configuration of the newly created stereogenic center as S (Figure 1). 
 
 
 
Figure 1. Molecular structure of the major diastereoisomer of adduct 3h. Displacement ellipsoids 
are drawn at the 30% probability level. 
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Adducts 3 are potential precursors to the corresponding β-amino acids, and it is worthy of note 
that oxazolidinone esters have been previously used as intermediates in the stereoselective 
syntheses of β-amino acids.24,25 The two steps needed to obtain a β-amino acid from an adduct 3 
are firstly the conversion of the diester moiety to a single carboxylic acid via an acidic hydrolysis 
followed by a decarboxylation, and secondly the cleavage of the oxazolidinone moiety leading to 
an amine function. 
As an example of such transformation, compound 3e was efficiently converted to the β-amino 
acid 5 in two steps. Thus, 3e was first heated in 6 N HCl for 15 h at 100 °C,26 leading to the acid 4 
in 53% yield, after two recrystallizations from diethyl ether. It should be noted that an attempt to 
hydrolyze the ester functions under basic conditions (LiOH, THF/H2O) resulted in retroaddition 
leading to oxazolidinone 1. The cleavage of the oxazolidinone ring was then cleanly realized by 
treating 4 with lithium in liquid ammonia,27,28 affording 3-amino-4-methylpentanoic acid (β-
leucine, 5) in 77% yield. 
The specific rotations reported for various samples of β-leucine have been recently compiled.5 
The specific rotation of 5 ([α]D20 –49.6. c 0.4, water) was in accord with those reported for the S 
isomer [lit.5 –53 (c 2.0, water)]. Thus the absolute chemistry of the stereogenic center created in the 
conjugate addition step is S, and the ee is 93%. 
 
 
 
Scheme 2. Two-step conversion of adduct 3e to (S)-β-leucine (5). 
 
A postulated 8-membered transition state leading to the observed major isomer is indicated in 
the Scheme 3. It involves an attack on the Re face of the electrophile. The side chain group of the 
alkylidenemalonate is in a pseudo-equatorial position, which takes into account the fact that the 
selectivity was enhanced as the side chain group was bulkier. Similar transition states have been 
postulated for reactions of oxazolidinone anions with other electrophiles.29,30 
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Scheme 3. Postulated transition state for the formation of the major adduct. 
 
 
Conclusions 
 
In summary, the potassium salt of (R)-4-phenyl-2-oxazolidinone reacts with dialkyl alkylidene-
malonates to afford the corresponding conjugate addition products. The diastereoselectivity of the 
reaction was better for electrophiles having more sterically demanding side chain groups, and 
diastereomeric excesses of 90% or more were obtained in several cases; although an electrophile 
bearing a bulky tert-butyl side chain was unreactive. The adduct obtained from the reaction 
involving dimethyl 2-(2-methylpropylidene)malonate was converted in two steps to the amino acid 
(S)-β-leucine, thus showing that the method permits a valuable enantioselective synthesis of the 
biologically important β-amino acids. 
 
 
Experimental Section 
 
General. 1H and 13C NMR spectra were recorded on a Bruker Advanced 400 spectrometer and 
chemical shifts are reported in ppm downfield from TMS for 1H and 13C NMR. IR spectra were 
recorded on a Perkin Elmer System 2000 FT-IR (liquid films or KBr pellets for solids). MS were 
recorded on a Mariner ESI TOF (Perseptive Biosystems) mass spectrometer. Mps were determined 
on a Büchi B-540 apparatus. HRMS were performed at the Service de Spectrométrie de Masse, 
ICSN, CNRS, Gif-sur-Yvette. Chromatographies were carried out using a CombiFlash system 
(Teledyne ISCO). TLCs were developed on silica gel 60F254 plates, with detection by UV light and 
by an ethanol solution of phosphomolybdic acid. THF was freshly distilled on sodium-
benzophenone. 
 
General procedure for the conjugate addition of (R)-4-phenyl-2-oxazolidinone to dialkyl 
alkylidenemalonates. (R)-4-Phenyloxazolidin-2-one (1.0 mmol) and potassium tert-butoxide (1.0 
mmol), were placed in a flask under argon atmosphere, cooled at 0 °C. THF (8 mL) was added and 
the white suspension obtained was stirred at 0 °C for 30 min and then cooled to -78 °C. A solution 
of the dialkyl alkylidenemalonate 2 (1.0 mmol) in THF (2 mL) cooled at 0 °C was added slowly 
and then the reaction mixture was stirred at -78 °C for 1-6 h. A saturated aqueous NH4Cl solution 
(5 mL) was added. The aqueous phase was extracted with diethyl ether (3 × 10 mL). The combined 
General Papers  ARKIVOC 2015 (v) 60-70 
Page 65 ©ARKAT-USA, Inc 
organic layers were washed with brine (10 mL), dried (MgSO4), filtered and concentrated under 
vacuum. The residue obtained was then purified by silica gel chromatography 
(cyclohexane/EtOAc) to afford the adduct 3. 
Diethyl 2-{1-[(R)-2-oxo-4-phenyloxazolidin-3-yl]ethyl}malonate (3a). This compound was 
obtained by the General Procedure (see Table 1, entry 2). Yield: 99%. 28% de. Colorless oil. IR 
(film) νmax 3055, 2987, 1754 (C=O), 1458, 1421, 1265, 1035, 896, 738, 705 cm–1. 1H NMR (400 
MHz, CDCl3): δ  (major isomer) 7.45-7.30 (m, 5H, Ar H), 4.87 (dd, J 8.7, 5.7 Hz, 1H, NCHPh), 
4.55 (t, J 8.7 Hz, 1H, CHHCHPh), 4.42 (dq, J 9.9, 6.9 Hz, 1H, CH3CHN), 4.32-4.10 (m, 5H, 
CHHCHPh and OCH2CH3), 3.92 (d, J 9.9 Hz, 1H, CHCO2), 1.35-1.20 (m, 6H, CH2CH3), 0.98 (d, J 
6.9 Hz, 3H, CHCH3) ppm; δ (minor isomer) 7.45-7.30 (m, 5H, Ar H), 4.91 (dd, J 9.0, 6.5 Hz, 1H, 
NCHPh), 4.55 (t, J 9.0 Hz, 1H, CHHCHPh), 4.32-4.10 (m, 6H, CHHCHPh, OCH2CH3 and 
CHCO2), 3.74 (dq, J 10.9, 6.9 Hz, 1H, CH3CHN), 1.35-1.20 (m, 6H, CH2CH3), 1.18 (d, J 6.9 Hz, 
3H, CHCH3) ppm. 13C NMR (100 MHz, CDCl3): δ (two isomers) 167.6, 167.2, 167.1, 157.9, 
156.6, 139.5, 138.4, 129.3, 129.2, 129.1, 127.8, 127.1, 70.6, 70.2, 62.5, 61.9, 61.7, 61.7, 58.7, 55.6, 
54.6, 49.6, 49.5, 16.7, 16.4, 13.9, 13.8 ppm. HRMS (ESI): calcd. for C18H24NO6 [M + H]+ 
350.1604; found 350.1605. 
Dimethyl 2-{1-[(R)-2-oxo-4-phenyloxazolidin-3-yl]propyl}malonate (3b). This compound was 
obtained by the General Procedure (see Table 1, entry 3). Yield: 37%. 67% de. Colorless crystals; 
mp 80-83 °C. IR (KBr pellet) νmax 2975, 2955, 2880, 1757 (C=O), 1458, 1434, 1413, 1321, 1271, 
1219, 1197, 1151, 1062, 1037, 1018, 962, 922, 859, 771, 759, 713, 632 cm–1. 1H NMR (400 MHz, 
CDCl3): δ (major isomer) 7.45-7.35 (m, 5H, Ar H), 4.89 (dd, J 8.8, 5.5 Hz, 1H, NCHPh), 4.57 (t, J 
8.8 Hz, 1H, CHHCHPh), 4.30-4.23 (m, 1H, NCHEt), 4.19 (dd, J 8.8, 5.5 Hz, 1H, CHHCHPh), 3.91 
(d, J 9.7 Hz, 1H, CHCO2), 3.72 (s, 3H, OCH3), 3.70 (s, 3H, OCH3), 1.42-1.34 (m, 1H, CHHCH3), 
1.24-1.17 (m, 1H, CHHCH3), 0.77 (t, J 7.2 Hz, 3H, CH2CH3) ppm. 13C NMR (100 MHz, CDCl3): δ 
(major isomer) 167.5 (CO2Me), 167.4 (CO2Me), 158.3 (C=O), 139.3, 129.0 (2C), 128.3 (2C), 
127.3, 70.6 (CH2OCO), 59.2 (CHEt), 55.8 (CHPh), 52.7 (CH(CO2Et)2), 52.7 (OCH3), 52.6 
(OCH3), 23.8 (CH2CH3), 10.7 (CH3) ppm. HRMS (ESI): calcd. for C19H26NO6 [M + H]+ 336.1447; 
found 336.1456. 
Dimethyl 2-{1-[(R)-2-oxo-4-phenyloxazolidin-3-yl]hexyl}malonate (3c). This compound was 
obtained by the General Procedure (see Table 1, entry 4). Yield: 43%. 45% de. Colorless oil. IR 
(film) νmax 2955, 2860, 1754 (C=O), 1459, 1435, 1411, 1222, 1158, 1042, 762, 735, 704 cm–1. 1H 
NMR (400 MHz, CDCl3): δ (major isomer) 7.45-7.30 (m, 5H, Ar-H), 4.87 (dd, J 8.7, 5.0 Hz, 1H, 
NCHPh), 4.56 (t, J 8.7 Hz, 1H, CHHCHPh), 4.38 (m, 1H, NCHC5H11), 4.19 (dd, J 8.7, 5.0 Hz, 1H, 
CHHCHPh), 3.84 (d, J 9.9 Hz, 1H, CHCO2), 3.72 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 1.30-0.90 
(m, 8H, CH2), 0.76 (t, J 7.4Hz, 3H, CH2CH3) ppm. 13C NMR (100 MHz, CDCl3): δ (major isomer) 
167.5 (2 CO2Me), 158.4 (C=O), 139.7, 129.0 (2C), 128.3 (2C), 127.2, 70.7 (CH2OCO), 58.7 
(CHC5H11), 54.7 (CHPh), 54.5 (CH(CO2Et)2), 52.7 (OCH3), 52.6 (OCH3), 31.0, 30.7, 25.8, 22.2, 
13.8 (CH3) ppm. HRMS (ESI): calcd. for C20H28NO6 [M + H]+ 378.1917. found 378.1899. 
Dimethyl 2-{3-methyl-1-[(R)-2-oxo-4-phenyloxazolidin-3-yl]butyl}malonate (3d). This 
compound was obtained by the General Procedure (see Table 1, entry 5). Yield: 65%; 41% de. 
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Colorless oil. IR (film) νmax 3055, 2987, 2930, 2306, 1754 (C=O), 1422, 1265, 896, 738, 705 cm–1. 
1H NMR (400 MHz, CDCl3): δ (major isomer) 7.42-7.34 (m, 5H, Ar-H), 4.85 (dd, J 8.6, 4.7 Hz, 
1H, NCHPh), 4.65-4.51 (m, 2H, CHHCHPh, NCHCH2iPr), 4.20 (dd, J 8.6, 4.7 Hz, 1H, 
CHHCHPh), 3.89 (m, 1H, CHCO2), 3.73 (s, 6H, OCH3), 1.40-1.30 (m, 1H, CHMe2), 1.15-1.05 (m, 
1H, CHHiPr), 0.90 (d, J 6.5 Hz, 3H, CH3), 0.90-0.80 (m, 1H, CHHiPr), 0.33 (d, J 6.5 Hz, 3H, CH3) 
ppm. 13C NMR (100 MHz, CDCl3): δ (major isomer) 167.5 (CO2Me), 167.3 (CO2Me), 158.5 
(C=O), 140.2, 129.0 (2C), 128.9 (2C), 127.2, 70.8 (CH2CHPh), 58.1 (CHCH2iPr), 55.1 (CHPh), 
52.9 (CH(CO2Me)2), 52.8 (OCH3), 52.7 (OCH3), 39.6, 26.8, 24.3, 20.8 (CH3), 20.7 (CH3) ppm. 
HRMS (ESI): calcd. for C19H26NO6 [M + H]+ 364.1760; found 364.1774. 
Dimethyl 2-{2-methyl-1-[(R)-2-oxo-4-phenyloxazolidin-3-yl]propyl}malonate (3e). This 
compound was obtained by the General Procedure (see Table 1, entry 6). Yield: 60%; 91% de. 
Colorless oil. IR (film) νmax 3055, 2986, 2930, 2360, 2339, 2308, 1755 (C=O), 1436, 1419, 1265, 
1216, 1161, 1048, 909, 738, 705 cm–1. 1H NMR (400 MHz, CDCl3): δ (major isomer) 7.50-7.47 
(m, 2H, Ar-H), 7.39-7.33 (m, 3H, Ar-H), 5.09 (dd, J 8.6, 4.0 Hz, 1H, NCHPh), 4.52 (t, J 8.6 Hz, 
1H, CHHOCO), 4.19 (dd, J 8.6, 4.0 Hz, 1H, CHHOCO), 4.10-4.03 (m, 1H, NCHiPr), 4.00 (d, J 7.1 
Hz, 1H, CHCO2), 3.72 (s, 3H, OCH3), 3.70 (s, 3H, OCH3), 1.95-1.85 (m, 1H, CH(CH3)2), 0.77 (d, J 
6.8 Hz, 3H, CHCH3), 0.65 (d, J 6.6 Hz, 3H, CHCH3) ppm. 13C NMR (100 MHz, CDCl3): δ (major 
isomer) 168.4 (CO2Me), 167.9 (CO2Me), 158.7 (C=O), 140.0, 128.9 (2C), 128.8 (2C), 127.7, 71.0 
(CH2OCO), 60.2 (CHiPr), 59.3 (CHPh), 53.3 (CH(CO2Et)2), 52.8 (OCH3), 52.7 (OCH3), 29.1 
(CH(CH3)2), 19.9 (CH3), 19.8 (CH3) ppm. HRMS (ESI): calcd. for C18H24NO6 [M + H]+ 350.1604; 
found 350.1590. 
Dimethyl 2-{cyclohexyl[(R)-2-oxo-4-phenyloxazolidin-3-yl]methyl}malonate (3g). This 
compound was obtained by the General Procedure (see Table 1, entry 9). Yield: 21%. 94% de. 
Colorless oil. IR (film) νmax 3055, 2987, 2933, 2805, 1754 (C=O), 1421, 1265, 1151, 1056, 896, 
738, 705 cm–1. 1H NMR (400 MHz, CDCl3): δ (major isomer) 7.52-7.48 (m, 2H, Ar-H), 7.40-7.33 
(m, 3H, Ar-H), 5.11 (dd, J 8.6, 3.7 Hz, 1H, NCHPh), 4.52 (t, J 8.6 Hz, 1H, CHHOCO), 4.24 (dd, J 
8.6, 3.7 Hz, 1H, CHHOCO), 4.18-4.12 (m, 1H, NCHCy), 3.95 (d, J 6.9 Hz, 1H, CHCO2), 3.74 (s, 
3H, OCH3), 3.73 (s, 3H, OCH3), 1.78-1.64 (m, 5H, Cy-H), 1.34-1.11 (m, 5H, Cy-H), 1.50-1.35 (m, 
1H, Cy-H) ppm. 13C NMR (100 MHz, CDCl3): δ (major isomer) 168.7 (C=O), 168.2 (C=O), 158.8 
(C=O), 140.4, 128.8, 128.8, 127.8, 71.1 (CH2OCO), 59.2 (CHNPh), 59.2 (CHCy), 53.2 
(CH(CO2Me)2), 52.9 (OCH3), 52.8 (OCH3), 38.3, 30.8, 30.0, 26.9, 25.9, 25.3 ppm. HRMS (ESI): 
calcd. for C21H28NO6 [M + H]+ 390.1917; found 390.1923. 
Dimethyl 2-{[(R)-2-oxo-4-phenyloxazolidin-3-yl](phenyl)methyl}malonate (3h). This 
compound was obtained by the General Procedure (see Table 1, entry 12). Yield: 70%. 90% de. 
Colorless solid; after recrystallization the major isomer was obtained as colorless crystals; mp 110 
°C (Et2O). IR (film) νmax 3055, 2987, 1760 (C=O), 1421, 1265, 896, 738, 704 cm–1. 1H NMR (400 
MHz, CDCl3): δ (major isomer) 7.46-7.39 (m, 3H, Ar H), 7.36-7.23 (m, 7H, Ar H), 5.30 (d, J 12.0 
Hz, 1H, CHCHCO2), 4.59 (d, J 12.0 Hz, 1H, CHCO2), 4.55-4.40 (m, 2H, CHHOCO, NCHCH2O), 
4.05 (t, J 7.4 Hz, 1H, CHHOCO), 3.80 (s, 3H, OCH3), 3.38 (s, 3H, OCH3) ppm. 13C NMR (100 
MHz, CDCl3): δ (major isomer) 167.4 (C=O), 167.4 (C=O), 158.0 (C=O), 136.2, 135.9, 129.5, 
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129.3, 129.0, 128.9, 128.3, 128.2, 70.2 (CH2OCO), 60.9 (CH2CH2OCO), 57.6 (CHCH(CO2Me)2), 
53.6 (CH(CO2Me)2), 53.0 (OCH3), 52.6 (OCH3) ppm. HRMS (ESI): calcd. for C21H22NO6 [M + 
H]+ 384.1447; found 384.1438. 
(S)-4-Methyl-3-{(R)-2-oxo-4-phenyloxazolidin-3-yl}pentanoic acid (4). An aqueous solution of 6 
N HCl (7.5 mL) was added to dimethyl 2-{2-methyl-1-[(R)-2-oxo-4-phenyloxazolidin-3-yl]-
propyl}malonate (3e) (459 mg, 1.31 mmol). The reaction mixture was heated at 100 °C for 15 h. 
After cooling to room temperature, the aqueous phase was extracted with methylene chloride (3 × 
10 mL). The combined organic phases were washed with water (2 × 5 mL), dried (MgSO4), filtered 
and concentrated under vacuum afforded 294 mg of crude compound. After two recrystallizations 
the carboxylic acid 4 was obtained as colorless crystals (198 mg). Yield: 53%, 93% de. mp 137-140 
°C (Et2O). [α]D20 +31.2 (c 1.00, CH2Cl2). IR (KBr pellet) νmax 3160, 2991, 2955, 2938, 2871, 1746, 
1731, 1703 (C=O), 1491, 1462, 1429, 1380, 1380, 1337, 1265, 944, 855, 773, 750, 705 cm–1. 1H 
NMR (400 MHz, CDCl3): δ 7.39 (s, 5H, Ar H), 4.85 (dd, J 8.9, 6.6 Hz, 1H, NCHPh), 4.63 (t, J 8.9 
Hz, 1H, CHHOCO), 4.24 (dd, J 8.9, 6.6 Hz, 1H, CHHOCO), 3.60-3.50 (m, 1H, NCHiPr), 2.83 (dd, 
J 15.8, 9.6 Hz, 1H, CHHCO2H), 2.72 (dd, J 15.8, 4.7 Hz, 1H, CHHCO2H), 1.72-1.60 (m, 1H, 
CH(CH3)2), 0.90 (d, J 6.5 Hz, 3H, CH3), 0.83 (d, J 6.5 Hz, 3H, CH3) ppm. 13C NMR (100 MHz, 
CDCl3): δ 175.9 (CO2H), 158.5 (C=O), 138.4, 129.2, 129.1 (2C), 127.7 (2C), 70.2 (CH2OCO), 60.3 
(CHiPr), 58.0 (CHPh), 34.7 (CH2CO2H), 30.9 (CHCH3), 20.0 (CH3), 19.4 (CH3) ppm. HRMS 
(ESI): calcd. for C15H20NO4 [M + H]+ 278.1392; found 278.1385. 
(S)-3-Amino-4-methylpentanoic acid (5). A solution of 4-methyl-3-((R)-2-oxo-4-phenyl-
oxazolidin-3-yl)pentanoic acid (4) (51.2 mg, 0.185 mmol) in THF (6.5 mL) and t-BuOH (0.185 
mL) was cooled under argon at 0 °C. Lithium (13.2 mg, 10 equiv) was placed under argon in 
another flask equipped with a dry-ice condenser. After cooling at -78 °C, NH3 (13 mL) was flushed 
in. After 10 min, the solution of oxazolidinone 4 was added dropwise to the deep blue solution 
obtained. After stirring at -78 °C for 30 min, powdered NH4Cl (0.17 g) was added. The flask was 
allowed to warm to room temperature under a stream of nitrogen, which facilitated the elimination 
of ammonia. After concentration under vacuum, the residue obtained was purified using a DOWEX 
50WX42400 ion-exchange resin washed before-hand with water. The resin was eluted successively 
with water, then 0.1 M, 0.5 M and 1 M aqueous NH4OH. The content of each fraction was checked 
by thin-layer chromatography (ninhydrin). After concentration of the relevant fractions, (S)-3-
amino-4-methylpentanoic acid (5) was obtained as a colorless solid (18.6 mg). Yield: 77%. 
Colorless powder; mp 202-205 °C, lit.,5 197–198 °C. [α]D20 –49.6 (c 0.4, water), lit.,5 –53 (c 2.0, 
water). IR (KBr pellet) νmax 2965, 2355, 2131, 1728, 1712, 1554, 1535, 1468, 1390, 1324, 1246, 
1118, 1037, 708 cm–1. 1H NMR (400 MHz, D2O): δ 3.33 (m, 1H, CHN), 2.58 (dd, J 16.8, 4.2 Hz, 
1H, CHHCO2H), 2.40 (dd, J 16.8, 9.3 Hz, 1H, CHHCO2H), 1.95 (m, 1H, CHCH3), 1.00 (d, J 6.5 
Hz, 3H, CH3), 0.98 (d, J 6.5 Hz, 3H, CH3) ppm. 13C NMR (100 MHz, D2O): δ 178.5 (CO2H), 54.8 
(CHiPr), 35.9 (CH2CO2H), 30.0 (CHCH3), 17.4 (CH3), 17.2 (CH3) ppm. 
 
Crystallography. The data were collected at 150(2) K on a Nonius Kappa-CCD area detector 
diffractometer31 using graphite-monochromated Mo-Ka radiation (λ 0.71073 Å), and they were 
General Papers  ARKIVOC 2015 (v) 60-70 
Page 68 ©ARKAT-USA, Inc 
processed with HKL2000.32 No absorption correction was done. The structure was solved by direct 
methods with SHELXS-97 and refined by full-matrix least-squares on F2 with SHELXL-97.33 All 
non-hydrogen atoms were refined with anisotropic displacement parameters. In the absence of a 
suitable anomalous scatterer, the Friedel pairs have been merged, the absolute configuration of the 
unknown chiral centre being deduced from that of the known one. Crystal data for 3h (major 
isomer): C21H21NO6, M = 383.39, orthorhombic, space group P212121, a = 6.9024(4), b = 
14.8607(14), c = 18.8527(19) Å, V = 1933.8(3) Å3, Z = 4. Refinement of 255 parameters on 2122 
independent reflections out of 50852 measured reflections (Rint = 0.031) led to R1 = 0.044, wR2 = 
0.099, ∆ρmin = –0.22, ∆ρmax = 0.15 e Å–3. CCDC-990814 contains the supplementary 
crystallographic data for this paper. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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